Dow Jones Newswires: Celltrion shares rally in South Korea after EU OKs marketing of its COVID-19 treatment

No Comments
Uncategorized

Celltrion Inc.’s shares rallied Monday after the European Commission granted the South Korean biotech firm approval to market its COVID-19 antibody treatment.

Celltrion Inc.’s shares rallied Monday after the European Commission granted the South Korean biotech firm approval to market its COVID-19 antibody treatment.